Article
Influence of body mass index, cholesterol, triglycerides and steatosis on pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C in patients transplanted for HCV and alcoholic cirrhosis.
Hepato-gastroenterology - 1 Jan 2000
Testino Gianni, Sumberaz Alessandro, Ancarani A Ornella, Borro Paolo, Ravetti Gianluigi, Ansaldi Filippo, Andorno Enzo, Gentile Raffaella, Icardi Giancarlo
Abstract excerpt
Up to today no work has evaluated yet the importance of parameters such Body Mass Index (BMI), cholesterol, triglycerides (TGC) and hepatic percentage of steatosis in the response to therapy with Pegylated Interferon Alfa-2a and Ribavirin in patients with recurrent hepatitis C (genotype 1). 30 consecutive prospectively followed patients diagnosed with recurrent HCV were considered candidates for antiviral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.